Company Filing History:
2 out of 5,081 
2 out of 4 
1 out of 870 
Years Active: 2010-2013
Title: Monique Martin: A Pioneer in SARS Research
Introduction: Monique Martin, located in Chatenay Malabry, France, is an accomplished inventor with two patents to her name. Her work has significantly contributed to the understanding and treatment of severe acute respiratory syndrome (SARS).
Latest Patents: One of Monique's latest patents pertains to a novel strain of SARS-associated coronavirus. This patent, referenced as number 031589, encompasses nucleic acid molecules derived from the genomic sequence of the coronavirus, including proteins and peptides encoded by these molecules. Specifically, her research focuses on protein N, which holds potential applications as diagnostic reagents and even as a vaccine, showcasing her dedication to addressing critical public health challenges.
Career Highlights: Throughout her career, Monique has worked at prestigious institutions, including the Centre National de la Recherche Scientifique and University Paris 7. Her extensive research and dedication have cemented her reputation in the field of virology and infectious diseases.
Collaborations: Monique has collaborated with esteemed colleagues, including Sylvie Van Der Werf and Nicolas Escriou. These partnerships have bolstered her research efforts and facilitated groundbreaking discoveries in the realm of coronavirus research.
Conclusion: Monique Martin stands out as a leading inventor whose innovative work in the field of SARS research has the potential to make a lasting impact on global health. Her patents serve as a testament to her creativity and expertise, and her contributions continue to inspire future advancements in medical science.